← Browse by Condition
Medical Condition
membranous nephropathy
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT06341205 Phase 3
Recruiting
Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)
Enrollment
120 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
NCT06065852
Recruiting
National Registry of Rare Kidney Diseases
Enrollment
35,000 pts
Location
United Kingdom
Sponsor
UK Kidney Association